Process for synthesis of chiral cis-and trans-3-amino-4 substituted
pyrrolidine compounds
    3.
    发明授权
    Process for synthesis of chiral cis-and trans-3-amino-4 substituted pyrrolidine compounds 失效
    合成手性顺式和反式-3-氨基-4-取代的吡咯烷化合物的方法

    公开(公告)号:US5668164A

    公开(公告)日:1997-09-16

    申请号:US764418

    申请日:1996-12-12

    IPC分类号: C07D207/14 C07D413/06

    CPC分类号: C07D207/14

    摘要: Process for preparation of chiral cis-3,4-substituted pyrrolidine compounds having the formulas: ##STR1## and chiral 3,4-trans-substituted pyrrolidine compounds having the formulas: ##STR2## with the assistance of a streochemically directing chiral oxazolidinone moiety having the formula: ##STR3## wherein P, R and R.sup.1 are specifically defined, by sequential reaction of the compound or subsequent intermediates with an a,b-unsaturated add chloride, reaction with N-benzyl-N-(methoxymethyl)trimethyl-silylmethylamine and separating isomers by chromatography, hydrolytic removal of the oxazolidinone moiety, reaction with diphenylphosphoryl azide and triethylamine, and debenzylating; and novel intermediates of the process.

    摘要翻译: 具有下式的手性顺式-3,4-取代的吡咯烷化合物的方法:具有下式的具有下式的具有下式的手性3,4-反式取代的吡咯烷化合物:在具有磺酰化引导的手性恶唑烷酮部分的帮助下, 通过化合物或其后的中间体与α,β-不饱和氯化物的顺序反应,与N-苄基-N-(甲氧基甲基)三甲基甲硅烷基甲基胺和 通过色谱法分离异构体,恶唑烷酮部分的水解去除,与二苯基磷酰基叠氮化物和三乙胺的反应和脱苄基化; 和这个过程的新中间体。

    Process for synthesis of chiral cis- and trans-3-amino-4-substituted
pyrrolidine compounds
    4.
    发明授权
    Process for synthesis of chiral cis- and trans-3-amino-4-substituted pyrrolidine compounds 失效
    合成手性顺式和反式-3-氨基-4-取代的吡咯烷化合物的方法

    公开(公告)号:US5618949A

    公开(公告)日:1997-04-08

    申请号:US679043

    申请日:1996-07-12

    IPC分类号: C07D207/14 C07D207/09

    CPC分类号: C07D207/14

    摘要: Process for preparation of chiral cis-3,4-substituted pyrrolidine compounds having the formulas ##STR1## and chiral 3,4-trans-substituted pyrrolidine compounds having the formulas ##STR2## with the assistance of a stereochemically directing chiral oxazolidinone moiety having the formula ##STR3## wherein P, R and R.sup.1 are specifically defined, by sequential reaction of the compound or subsequent intermediates with an a,b-unsaturated acid chloride, reaction with N-benzyl-N-(methoxymethyl)trimethylsilylmethylamine and separating isomers by chromatography, hydrolytic removal of the oxazolidinone moiety, reaction with diphenylphosphoryl azide and triethylamine, and debenzylating; and novel intermediates of the process.

    摘要翻译: 具有式“IMAGE”的手性顺式-3,4-取代的吡咯烷化合物和具有式“IMAGE”的手性3,4-反式取代的吡咯烷化合物的方法在具有式(I)的立体化学引发的手性恶唑烷酮部分 其中P,R和R1通过化合物或其后的中间体与a,b-不饱和酰氯的顺序反应而具体定义,与N-苄基-N-(甲氧基甲基)三甲基甲硅烷基甲胺反应,并通过色谱法分离异构体, 水解除恶唑烷酮部分,与二苯基磷酰基叠氮化物和三乙胺反应,脱苄; 和新的中间体的过程。

    3-'N-modified 6-O-substituted erythromycin ketolide derivatives having
antibacterial activity
    10.
    发明授权
    3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity 有权
    具有抗菌活性的3-N改性的6-O-取代的红霉素酮内酯衍生物

    公开(公告)号:US06034069A

    公开(公告)日:2000-03-07

    申请号:US132256

    申请日:1998-08-11

    IPC分类号: C07H17/08 A61K31/70 C07H1/00

    CPC分类号: C07H17/08

    摘要: Novel 3'-N-modified 6-O-substituted erythromycin ketolide compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula ##STR1## compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention.

    摘要翻译: 具有抗细菌活性的新颖的3'-N-修饰的6-O-取代的红霉素酮内酯化合物及其药学上可接受的盐和酯,其具有包含治疗有效量的本发明化合物与药学上可接受的载体的组成的式 作为通过向哺乳动物施用含有治疗有效量的本发明化合物的药物组合物来治疗细菌感染的方法。